慢性肾脏病中的胆碱能抗炎通路:综述与迷走神经刺激临床先导研究
炎症和自主神经功能障碍在慢性及终末期肾病中常见,显著增加死亡风险。胆碱能抗炎通路(CAP)是维持炎症稳态的迷走神经免疫回路。本文综述CAP在急性肾损伤、慢性肾脏病(CKD)及高血压中的潜在作用,并报告一项血液透析患者的迷走神经刺激(VNS)先导研究,提示神经免疫调控可能为CKD提供新治疗方式。
要点
- CAP是迷走神经调控炎症的神经免疫回路,在CKD中可能具有保护作用。
- VNS植入在类风湿关节炎和炎症性肠病中显示潜在获益。
- 透析患者存在功能性CAP,VNS先导研究探索其临床可行性。
核心结论
- 通过神经免疫调控控制炎症可能为CKD患者改善治疗、结局、预后和生活质量带来新治疗模式。
研究设计与样本
- 综述结合一项在血液透析患者中开展的VNS先导研究。
主要发现
- 炎症和自主神经功能障碍在慢性及终末期肾病中常见,并与死亡风险显著增加相关。
- CAP是维持细胞损伤和病原体刺激下炎症活动稳态的迷走神经免疫回路。
- 既往研究显示透析患者的CAP在体外具有功能。
- VNS植入在类风湿关节炎和炎症性肠病等慢性自身免疫病中显示潜在获益。
临床怎么用
- 神经免疫调控(如VNS)可能成为CKD抗炎治疗的新方向,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammation and autonomic dysfunction are common findings in chronic and end-stage kidney disease and contribute to a markedly increased risk of mortality in this patient population. The cholinergic anti-inflammatory pathway (CAP) is a vagal neuro-immune circuit that upholds the homoeostatic balance of inflammatory activity in response to cell injury and pathogens. CAP models have been examined in preclinical studies to investigate its significance in a range of clinical inflammatory conditions and diseases. More recently, cervical vagus nerve stimulation (VNS) implants have been shown to be of potential benefit for patients with chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. We have previously shown that dialysis patients have a functional CAP ex vivo. Here we review the field and the potential role of the CAP in acute kidney injury and chronic kidney disease (CKD) as well as in hypertension. We also present a VNS pilot study in haemodialysis patients. Controlling inflammation by neuroimmune modulation may lead to new therapeutic modalities for improved treatment, outcome, prognosis and quality of life for patients with CKD.
引用
- Hilderman M, Bruchfeld A. The cholinergic anti-inflammatory pathway in chronic kidney disease-review and vagus nerve stimulation clinical pilot study. Nephrol Dial Transplant. 2020. PMID: 33151338. doi:10.1093/ndt/gfaa200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。